Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1726 Views
-
Last post by goellerc
-
- 0 Replies
- 1131 Views
-
Last post by ElliotB
-
- 61 Replies
- 13575 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4897 Views
-
Last post by NHE
-
- 5 Replies
- 13706 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1529 Views
-
Last post by ElliotB
-
- 0 Replies
- 806 Views
-
Last post by DIM
-
- 0 Replies
- 477 Views
-
Last post by NHE
-
- 0 Replies
- 1553 Views
-
Last post by NHE